Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7729157 | 0.96 | KCNH2 (0.56) | KCNH2 | |
| SCHEMBL7725404 | 0.96 | KCNH2 (0.59) | KCNH2 | |
| SCHEMBL7725735 | 0.95 | KCNH2 (0.59) | KCNH2 | |
| SCHEMBL7726916 | 0.95 | KCNH2 (0.59) | KCNH2 | |
| SCHEMBL7726599 | 0.94 | KCNH2 (0.57) | KCNH2 | |
| SCHEMBL7731006 | 0.93 | KCNH2 (0.57) | KCNH2 | |
| SCHEMBL7732412 | 0.93 | KCNH2 (0.57) | KCNH2 | |
| SCHEMBL7721433 | 0.93 | KCNH2 (0.56) | KCNH2 | |
| SCHEMBL7728159 | 0.93 | KCNH2 (0.56) | KCNH2 | |
| SCHEMBL7725738 | 0.93 | KCNH2 (0.56) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1218370-B1 | QUINOLYL PROPYL PIPERIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | AVENTIS PHARMA SA (FR) | 2004-12-08 | — | — | EP | disclosed |
| EP-1218370-A2 | QUINOLYL PROPYL PIPERIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | Aventis Pharma S.A. (FR) | 2002-07-03 | — | — | EP | disclosed |
| US-6403610-B1 | ANTIMICROBIAL AGENTS | AVENTIS PHARMA S.A. (FR) | 2002-06-11 | — | — | US | disclosed |
| WO-2001025227-A2 | QUINOLYL PROPYL PIPERIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | AVENTIS PHARMA S.A. (FR) | 2001-04-12 | — | — | WO | disclosed |